Stock Events

Stock Events

H. Lundbeck AS 

$0
19
+$0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

11NovExpected
Q3 2024
Q1 2025
Q3 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

12.91%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
7.66BRevenue
988.97MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HLBBY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap156.77B
Pfizer is a global pharmaceutical company that competes with Lundbeck in the development and marketing of drugs for psychiatric and neurological disorders.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the same therapeutic areas as Lundbeck, including mental health.
Novartis
NVS
Mkt Cap293.34B
Novartis offers products in neurology and psychiatry, directly competing with Lundbeck's portfolio.
Lilly(Eli) &
LLY
Mkt Cap829.71B
Eli Lilly has a strong presence in the psychiatric medication market, making it a direct competitor to Lundbeck.
Merck
MRK
Mkt Cap294.39B
Merck & Co. competes with Lundbeck in the area of brain health, including treatments for neurological conditions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap38.65B
Teva Pharmaceutical Industries has a broad portfolio that includes CNS (central nervous system) drugs, competing with Lundbeck.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie, with its neuroscience division, offers products that compete in the same space as Lundbeck's treatments.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol Myers Squibb has a range of psychiatric and neurological drugs, positioning it as a competitor to Lundbeck.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca operates in various therapeutic areas, including those that overlap with Lundbeck's CNS focus.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline has a diversified portfolio that includes medications for mental health, competing with Lundbeck.

About

Lindbergh S.p.A., together with its subsidiaries, provides logistics services in Italy and France. The company offers logistics services for networks of field maintenance technicians, including night-time spare parts delivery, special waste and returns management, spare parts stock management, tools management and testing, and onsite services, as well as supply of tools, PPE, and consumables services. It is also involved in circular economy projects, as well as servicing and installing activities in the heating, ventilation, and air conditioning sector. The company was founded in 2006 and is based in Cremona, Italy.
Show more...
CEO
Mr. Marco Pome
Employees
300
Country
Italy
ISIN
US40422M4042

Listings

F
DE
D8M.F
Grey Market
US
LDBMF
STU
DE
LDBA.STU
MU
DE
LDBA.MU

0 Comments

Share your thoughts

FAQ

What is H. Lundbeck AS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange H. Lundbeck AS stocks are traded under the ticker HLBBY.
What is H. Lundbeck AS revenue for the last year?▼
H. Lundbeck AS revenue for the last year amounts to 7.66B USD.
What is H. Lundbeck AS net income for the last year?▼
HLBBY net income for the last year is 988.97M USD.
How many employees does H. Lundbeck AS have?▼
As of April 24, 2026, the company has 300 employees.
In which sector is H. Lundbeck AS located?▼
H. Lundbeck AS operates in the Other sector.
When did H. Lundbeck AS complete a stock split?▼
H. Lundbeck AS has not had any recent stock splits.
Where is H. Lundbeck AS headquartered?▼
H. Lundbeck AS is headquartered in Cremona, Italy.